Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other hematologic neoplasm 1

Conditions

Hypoxia 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Radiosurgery 6 pembrolizumab 5 Oncolytic Virotherapy 4 Magnetic Resonance Spectroscopy 4 Fluorodeoxyglucose F18 4 Carboplatin 4 Paclitaxel 3 Cyclophosphamide 3 Cisplatin 3 osimertinib 2 atezolizumab 2 aldesleukin 2 Tobacco Use Cessation Devices 2 Specimen Handling 2 Radiotherapy 2 Positron-Emission Tomography 2 Pemetrexed 2 Nivolumab 2 Docetaxel 2 toripalimab 1 sugemalimab 1 sodium thiosulfate 1 perflutren 1 palbociclib 1 icotinib 1 gallium 68 PSMA-11 1 fludarabine 1 durvalumab 1 dapagliflozin 1 dacomitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Atovaquone × Thoracic × Clear all

NCT02628080 2019-09-04

ATOM

University of Oxford

Phase EARLY_PHASE1 Completed

Hypoxia, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡